unknown
Stage
About
Cassava Sciences is a clinical-stage biotechnology company developing therapies for neurodegenerative diseases, primarily Alzheimer’s disease, and is developing the drug candidate simufilam.
Explore Cassava Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.